<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231004059612N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-10-28</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of sleep hygiene education and diet based on Persian traditional medicine texts on the results of in vitro fertilization (IVF/ICSI) of infertile women</public_title>
      <acronym></acronym>
      <scientific_title>The effect of sleep hygiene education and diet based on Persian traditional medicine texts on the results of in vitro fertilization (IVF/ICSI) of infertile women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>124</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73060</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Blocking will be done by randomization method. The randomization unit of infertile women is classified into age groups of less than 30, 30 to 34, 35 to 39, and 40 to 45 years, stratified random allocation will be done in each of the age groups. In total, 31 blocks of 4 will be used for allocation. The random allocation process will be done with Random Allocation 2.0 software.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Primary or secondary infertility of women with ovarian or unexplained causes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group: For the people of the intervention group, two face-to-face sessions will be held by an expert in traditional Iranian medicine and a researcher. Each meeting will be held for 60 minutes at the Obstetrics and Gynecology Department of Imam Khomeini Hospital (RA) in Sari, in most of 12 groups of 10 people, with an interval of one week from each other (46-48). Most of the PowerPoint content will be presented to the patients. In the first session, recommendations related to lifestyle and health improvement in the area of sleep based on Iranian traditional medicine texts, and in the second session, recommendations related to dietary compliance based on Iranian traditional medicine texts will be presented, and the content package "diet, sleep" And the 147-item standard food frequency questionnaire (Food Frequency Questionnaire) whose validity and reliability have been measured and confirmed with Spearman's correlation coefficient of 0.47-0.69 in research conducted in Iran (51-49) will be presented. Completing the food frequency questionnaire by the patients is to know the type and amount of food consumed by them during the intervention. The control group will receive the usual treatments. The duration of observing the diet and sleep package is three months (19, 31), which begins with the onset of the patient's menstrual period. Individuals will be followed up to implement diets and sleep. The researcher will follow up by phone once a week and in person once a month. At the end of the second month and after two periods of menstruation, the subjects in the study enter the IVF/ICS cycle. Two weeks after IVF, a small B-hcg test is checked to check for chemical pregnancy. If the result of the test is positive, one month later, an ultrasound will be performed by a radiologist to check the fetal heart and clinical pregnancy(52). The follow-up of patients who have a positive clinical pregnancy will be continued by the researcher until the 12th week of pregnancy. At the end of the study, IVF/ICSI success is measured in two groups. Intervention 2: Control group: Control group: will not receive any intervention before in vitro fertilization.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The study has not yet entered the implementation phase and a specific decision has not been made regarding this matter.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>seyede sedighe yousofi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabaristan St, Khazar Square</address>
        <city>sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4848157945</zip>
        <telephone>+98 11 3324 3117</telephone>
        <email>dr_ssyosefi@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>seyede sedighe yosefi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabarestan Street, Khazar Square</address>
        <city>sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4848157945</zip>
        <telephone>+98 11 3324 3117</telephone>
        <email>dr_ssyosefi@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Primary or secondary infertile women with ovarian problems or unexplained causes</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Infertility with anatomical or male causes with sleep disorders and diabetes</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N97.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Female infertility, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: For the people of the intervention group, two face-to-face sessions will be held by an expert in traditional Iranian medicine and a researcher. Each meeting will be held for 60 minutes at the Obstetrics and Gynecology Department of Imam Khomeini Hospital (RA) in Sari, in most of 12 groups of 10 people, with an interval of one week from each other (46-48). Most of the PowerPoint content will be presented to the patients. In the first session, recommendations related to lifestyle and health improvement in the area of sleep based on Iranian traditional medicine texts, and in the second session, recommendations related to dietary compliance based on Iranian traditional medicine texts will be presented, and the content package "diet, sleep" And the 147-item standard food frequency questionnaire (Food Frequency Questionnaire) whose validity and reliability have been measured and confirmed with Spearman's correlation coefficient of 0.47-0.69 in research conducted in Iran (51-49) will be presented. Completing the food frequency questionnaire by the patients is to know the type and amount of food consumed by them during the intervention. The control group will receive the usual treatments. The duration of observing the diet and sleep package is three months (19, 31), which begins with the onset of the patient's menstrual period. Individuals will be followed up to implement diets and sleep. The researcher will follow up by phone once a week and in person once a month. At the end of the second month and after two periods of menstruation, the subjects in the study enter the IVF/ICS cycle. Two weeks after IVF, a small B-hcg test is checked to check for chemical pregnancy. If the result of the test is positive, one month later, an ultrasound will be performed by a radiologist to check the fetal heart and clinical pregnancy(52). The follow-up of patients who have a positive clinical pregnancy will be continued by the researcher until the 12th week of pregnancy. At the end of the study, IVF/ICSI success is measured in two groups</i_keyword>
      <i_keyword>Control group: Control group: will not receive any intervention before in vitro fertilization.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The number of eggs. Timepoint: before the start of the intervention and after the completion of the intervention. Method of measurement: the number of eggs by ultrasound of the ovary.</prim_outcome>
      <prim_outcome>The number of mature eggs. Timepoint: After the intervention. Method of measurement: The number of mature eggs is measured with a stereomicroscope.</prim_outcome>
      <prim_outcome>The number of embryos. Timepoint: After the intervention. Method of measurement: Morphological examination of the fetus.</prim_outcome>
      <prim_outcome>The quality of embryos. Timepoint: After the intervention. Method of measurement: Morphological examination of the fetus.</prim_outcome>
      <prim_outcome>The rate of fertilization. Timepoint: after the intervention. Method of measurement: Fertilization rate is the ratio of the number of fertilized eggs to the number of mature eggs.</prim_outcome>
      <prim_outcome>The rate of implantation. Timepoint: after the intervention. Method of measurement: the implantation rate is defined as the number of gestational sacs seen in ultrasound divided by the total number of embryos.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The spontaneous pregnancy rate. Timepoint: after the end of the intervention. Method of measurement: Spontaneous pregnancy rate based on ultrasound.</sec_outcome>
      <sec_outcome>Chemical pregnancy. Timepoint: after the end of the intervention. Method of measurement: based on quantitative beta test (B-HCG).</sec_outcome>
      <sec_outcome>Clinical pregnancy. Timepoint: after the intervention. Method of measurement: Based on ultrasound.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-02</approval_date>
        <contact_name>Ethics committee of mazandaran University of Medical Sciences</contact_name>
        <contact_address>ساری- میدان معلم- ساختمان شماره2 دانشگاه علوم پزشکی و خدمات بهداشتی درمانی sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
